News: Spotlight Content

Brooks Properties well positioned to play major role in helping biotech firms locate or expand in Massachusetts

Gov. Deval Patrick's $1 billion initiative to encourage biotechnology research and development in Massachusetts represents the direction of the future for industry in the region - and Brooks Properties is well positioned to play a major role in that future. The governor's proposal to fund academic research and startup biotech firms over 10 years underscores what many firms have already discovered: With its globally recognized academic and scientific communities, and its world-renowned medical facilities, Massachusetts is the ideal place for locating or expanding companies invested in biotechnology. And the field is expanding rapidly. Growth in the biotechnology-related workforce has been averaging 12.3% annually in recent years, according to the U.S. Department of Commerce, with the biggest growth occurring in small companies of 50 to 499 employees. In Massachusetts, biotechnology employment grew 25.6% between 2001 and 2005, according to the U.S. Bureau of Labor Statistics and the Massachusetts Biotechnology Council - an increase of more than 8,700 jobs. Companies that locate here are also likely to stay. Because of the local brainpower and availability of turnkey facilities, biotech firms have little incentive to export their business to places like China or Mexico, as many manufacturing companies have done. Brooks Properties, a commercial and industrial development company based in the Merrimack Valley, is uniquely situated to help biotech firms take advantage of the governor's proposal. "It's the kind of business Massachusetts needs and the kind of buildings we want to build and renovate," said company president Joe Friedman. Brooks Properties already has some 207,000 s/f of available, dividable space that lends itself to biotechnical use, and permits are in place for another 36,000 s/f. Most properties are located along the I-93 corridor in northern Massachusetts and southern New Hampshire. With leasing now priced at $6 to $18.50 per s/f compared to rents of $30 to $90 per s/f in and around central Boston, the properties represent both value and convenience for firms seeking to build or relocate. The company "has such valuable properties in the red zone for the life sciences industry," said Peter Abair, director of economic development for the Massachusetts Biotechnology Council. "The readiness of these properties to host life sciences opportunities, along with this initiative, is a winning combination." In addition, Brooks Properties has more than 25 years of experience providing turnkey facilities for clients ranging from complex specialized biomedical firms to data centers, solid working relationships with economic development directors in both Massachusetts and New Hampshire and a decades-old reputation for quality work. "They're terrific," said Peter Milano, senior regional director for the Massachusetts Office of Business Development. "We have worked together on several occasions, mostly on fairly sizable companies, and they're very responsive." The company is expert at tailoring space to the particular needs of clients, as it has seen its tenant roster change from distribution companies and light manufacturers using 54,000 to 200,000 s/f to much smaller and more diverse companies. Among the specialized tenants with which the company has worked are dialysis provider Fresenius Medical Care, Valley Regional Health, Access Health, Injured Workers Pharmacy, Boston Analytical, Aurora Diagnostics and Quest Labs. The governor's initiative, announced in May, must still be approved by the state legislature before it can be implemented but it has already drawn a favorable reception. "The legislature certainly wants to support the life sciences industry in Massachusetts because it really is a growth industry," said Abair. The governor's initiative is important, he adds, because the state now relies on traditional incentive programs to attract industry "and they aren't really a good fit for biotech firms, which are doing research and development and aren't making products yet. This initiative provides gap funding that's so critical to research and development." John DiNapoli, director of business services for the Massachusetts Alliance for Development, a non-profit, membership-driven organization, points out that the proposal has the potential for creating an unlimited number of jobs if, for example, a researcher makes a disease-preventing discovery that leads to an FDA-approved product. The managers at Brooks Properties say they are willing and prepared to play a key role in implementing the governor's initiative. The company, founded in 1980 by Lawrence native Harold Brooks, owns and maintains more than 40 properties with a combined 1.5 millions s/f of space. Today, it is managed by Brooks and his children, Eric Brooks and Julie Brooks, along with company president Joe Friedman.
MORE FROM Spotlight Content

Check out the New England Real Estate Journal's 2025 Fall Preview Spotlight

NEREJ’s Fall Preview is Out Now!
Explore our Fall Preview Spotlight, featuring exclusive Q&As with leading commercial real estate professionals and in-depth byline articles on today’s most relevant market topics. Gain insight into the trends, challenges, and opportunities shaping New England’s commercial real estate landscape this fall.  
READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
How long should I hold a property for it to qualify as an investment property in connection with a 1031 tax-deferred exchange? - by Brendan Greene and Mark McCue

How long should I hold a property for it to qualify as an investment property in connection with a 1031 tax-deferred exchange? - by Brendan Greene and Mark McCue

Internal Revenue Code (IRC) Section 1031 provides “No gain or loss shall be recognized on the exchange of property held for productive use in a trade or business or for investment if such property is exchanged solely for property of like kind which is to be held
Shallow-bay wins on 495/128:  A renewal-driven market with a thin pipeline - by Nate Nickerson

Shallow-bay wins on 495/128: A renewal-driven market with a thin pipeline - by Nate Nickerson

The Boston industrial market entered mid-2025 in a bifurcated state. Large-block vacancy remains elevated, while shallow-bay along the 495/128 corridor continues to prove resilient. Fieldstone’s focus on this geography positions us squarely in the middle of a renewal-driven, supply-constrained
30 years on South Coast Rail: A journey to connect Southeastern Mass. with commuter rail - by Rick Carey

30 years on South Coast Rail: A journey to connect Southeastern Mass. with commuter rail - by Rick Carey

On March 24, 2025, a dream more than three decades in the making became a reality with the launch of the Massachusetts Bay Transportation Authority’s (MBTA) South Coast Rail commuter service. This milestone marks the completion of a project that overcame numerous starts and stops, including changes in leadership
How do we manage our businesses in a climate of uncertainty? - by David O'Sullivan

How do we manage our businesses in a climate of uncertainty? - by David O'Sullivan

These are uncertain times for the home building industry. We have the threat of tariffs mixed with high interest rates and lenders nervous about the market. Every professional, whether builder, broker, or architect, asks themselves, how do we manage our business in today’s climate? We all strive not just to succeed, but